tiprankstipranks
Inmode (INMD)
NASDAQ:INMD
US Market
Want to see INMD full AI Analyst Report?

InMode (INMD) Blogger Opinions & Sentiment

2,074 Followers

Blogger Sentiment

Bullish: 80.00%
Sector Average
Bullish
INMD Blogger sentiment is based on 5 Blogger Opinions. The Blogger sentiment is more Bullish than other stocks in the Healthcare sector.

Blogger Article Distribution

ArticleDistribution
60% SeekingAlpha
20% GuruFocus
20% Investing
The distribution of articles among the main online Financial Blogging platforms.

Top Blogger Bearish Predictions

InMode: It's Time To Exit The Theater (Rating Downgrade)
SeekingAlpha
Recent negative articles by top bloggers.

Top Blogger Bullish Predictions

Medical devices sector outlook: value opportunities amid 2026 selloff
Investing
InMode (INMD) Set to Release Q4 Earnings with Positive Expectations
GuruFocus
InMode: Discounted Valuation And Strong Fundamentals Make It A Buy
SeekingAlpha
Recent positive articles by top bloggers.

Financial Blogger Predictions​​

Blogger Performance
Any
Any
Blogger Sentiment
Any
Any

FAQ

What do Seeking Alpha bloggers think of INMD?
Seeking Alpha’s Clover Biotech Research has a Bearish Sentiment.
    What do Motley Fool contributors think of INMD?
    Currently there's no blogger sentiment for INMD.
    What Is INMD’s Blogger Sentiment?
    INMD’s Blogger Sentiment is Bullish.
      What was the most recent blogger prediction for INMD?
      The most recent blogger prediction for INMD was made by UK, who was Bullish on the stock.
        How can I follow the stock ratings of top Top Financial Bloggers?
        Head over to our Expert Center to see a list of the Top 100 Financial Bloggers and follow the financial bloggers of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Stocks with the Highest Top Blogger Ratings in the Healthcare sector
          SMMTSummit Therapeutics
          CNCCentene
          TGTXTG Therapeutics
          ACADACADIA Pharmaceuticals
          HUMHumana